May 13, 2015
ASKA Pharmaceutical enjoyed higher sales and profits in FY2014, driven by its authorized generic (AG) version of Takeda Pharmaceutical’s blockbuster hypertension drug Blopress (candesartan), which hit the shelves in Japan last September. The mid-sized Japanese drug maker said on May...read more